Dawson P, Opacka-Juffry J, Moffatt JD, Daniju Y, Dutta N, Ramsey J, Davidson C. (2013)The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Sep 4. doi:pii: S0278-5846(13)00187-5. 10.1016/j.pnpbp.2013.08.013. [Epub ahead of print]
Petros N, Opacka-Juffry J, Huber JH. (2013) Psychometric and neurobiological assessment of resilience in a non-clinical sample of adults. Psychoneuroendocrinology. doi:pii: S0306-4530(13)001170.10.1016/j.psyneuen.2013.03.022. [Epub ahead of print]
Wells L, Opacka-Juffry J, Fisher D, Ledent C, Hourani S, Kitchen I. (2012)In vivo dopaminergic and behavioral responses to acute cocaine are altered in adenosine A(2A) receptor knockout mice. Synapse 66(5):383-90.doi: 10.1002/syn.21527. Epub 2012 Feb 15.
Leventopoulos M., Russig H., Feldon J., Pryce C.R. and Opacka-Juffry J. (2009) Early deprivation leads to long-term reductions in motivation for reward and 5-HT1A binding and both effects are reversed by fluoxetine. Neuropharmacology 56: 692-701
Opacka-Juffry J. (2008) Serotonin as a Neurotransmitter in Health and Illness - invited review. Br. J. Neurosci. Nursing 4, 6, 272-277
Castane A., Wells L., Soria G., Hourani S., Ledent C., Kitchen I., Opacka-Juffry J., Maldonado R. and Valverde O. (2008) Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A2A receptor knockout mice. Br. J. Pharmacol., 155:757-66
Leventopoulos M., D. Rüedi-Bettschen, C. R. Pryce, I. Knüsel, P. Feldon and J. Opacka–Juffry (2007) Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Res., 1142: 119-126.
Idiculla J., Shirazi N., Opacka-Juffry J. and Ganapathi (2004) Diabetic amyotrophy: a brief review. Natl. Med. J. India, 17: 200-202.
Stanley S.A., K.G. Murphy, G.A. Bewick, W.M. Kong, J.Opacka-Juffry, J.V. Gardiner, M. Ghatei, C.J. Small and S.R. Bloom (2004) Regulation of pituitary cocaine- and apmhetamine-regulated transcript (CART) by CRF and glucocorticoids. Am. J. Physiol. (Endocrinology and Metabolism) 287: 583-90.
Hume S.P., E. Hirani, J. Opacka-Juffry, R. Myers, C. Townsend, V.W. Pike and P. Grasby (2001) Effect of 5-HT on binding of [11C] WAY 100635 to 5-HT1A receptor in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 41: 150-159.
Hirani, E., J. Gillies, A. Karasawa, J. Shimada, H. Kase, J. Opacka-Juffry, S. Osman, S.K. Luthra, S.P. Hume and D. J. Brooks (2001) Evaluation of [4-O-methyl-11C]KW-6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats. Synapse 42: 164-176.
Hirani, E., J. Opacka-Juffry, R. Gunn, I. Khan, T. Sharp and S.P. Hume (2000) Pindolol occupancy of 5-HT1A receptors measured in vivo using small animal positron tomography with carbon-11 labelled WAY 100635 Synapse, 36: 330-341.
Taheri, S., M. Mahmoodi, J. Opacka-Juffry, M.A. Ghatei, S.R. Bloom (1999), Distribution and quantification of immunoreactive orexin A in rat tissues, FEBS Lett., 457: 157-61.
Opacka-Juffry J., E. Hirani, G.R. Dawson, S.K. Luthra and S.P. Hume (1999) Evaluation of [methyl-3H]L655,708 and [ethyl-3H]RY80 as putative PET ligands for central GABAA receptors containing alfa-5 subunit, Nucl. Med. Biol., 26: 743-748.
Sullivan, A.M., J. Opacka-Juffry, J. Pohl and S.B. Blunt (1999) Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration, Brain Res., 818: 176-179.
Opacka-Juffry, J., A.W. Wilson and S.B. Blunt (1998) Effects of pergolide treatment on in vivo hydroxyl radical production during 6-hydroxydopamine infusion in rat striatum, Brain Res., 810: 27-33.
Opacka-Juffry, J., S. Ashworth, R.G. Ahier and S.P. Hume (1998) Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET, J. Neural Transm., 105: 349-364.
Sullivan, A.M., J.Opacka-Juffry and S.B. Blunt (1998) Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopaminbe in vivo, Eur. J. Neurosci., 10: 57-63.
Fricker, R.A., E.M. Torres, S.P. Hume, R. Myers, J. Opacka-Juffry, S. Ashworth and S.B. Dunnett (1997) The effects of donor stage on the survival and function of embryonic striatal grafts: II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79, 711-721.
Sullivan, A.M., J. Opacka-Juffry, G. Hotten, J. Pohl and S.B. Blunt (1997) Growth/differentiation factor5 protects nigrostriatal dopaminergic neurones in rat model of Parkinson's disease. Neurosci. Letters 233, 73-76.
Opacka-Juffry, J. S. Ashworth, A.M. Sullivan, R.B. Banati and S.B. Blunt (1996) Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into rat striatum. J. Neural Transm. 103, 1429-1434.
Opacka-Juffry, J. S. Ashworth, S.P. Hume, D.J. Brooks and S.B. Blunt (1995) GDNF protects against 6-OHDA nigrostriatal lesion. Neuroreport 7, 348-352.
Torres, E.M., R.A. Fricker, S.P. Hume, R. Myers, J. Opacka-Juffry, S. Ashworth, D.J. Brooks and S.B. Dunnett (1995) Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner. Neuroreport 6: 2017-2021.
Hume, S.P., J. Opacka-Juffry, R. Myers, R.G. Ahier, S. Ashworth, D.J. Brooks and A.A. Lammertsma (1995) Effects of L-DOPA and 6-OHDA lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse 21, 45-53.
Opacka-Juffry J., and D.J. Brooks (1995) L-DOPA and its decarboxylase - new ideas on their neuroregulatory roles - a review. Movement Disorders 10, 241-249.
Pike, V.W., J.A. McCarron, S.P. Hume, S. Ashworth, J. Opacka-Juffry, S. Osman, A.A. Lammertsma, K.G. Poole, A . Fletcher, A.C. White and I.A. Cliffe (1994) Preclinical development of a radioligand for studies of central 5-HT1A receptors in vivo-[11C]WAY-100635, Med. Chem. Res. 5, 208-227 (Study awarded a Marie Curie Prize in Nuclear Medicine, 1995).
Hume, S.P. ,S. Ashworth, J. Opacka-Juffry, R.G. Ahier, S, A.A. Lammertsma, V.W. Pike, I.A. Cliffe, A.Fletcher and A.C. White (1994) Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain, Eur. J. Pharmacol. 271, 515-523.
Shende V.H, Pryce C.R., D. Rüedi-Bettschen D, Rae T.C. and Opacka–Juffry J. (2012) Evidence for long-term remodelling of hippocampal volume and astroglia following early life stress in Wistar rats. Recent Devel. Brain Res., 1; 99-117.ISBN: 978-81-308-0505-4
Opacka-Juffry J. and S.P. Hume (2006) Modulatory effects of levodopa on D2 dopamine receptors in rat striatum assessed using in vivo microdialysis and PET. Pages 261-275 in 'Neurobiology of DOPA as a Neurotransmitter' Editors Misu Y. and Goshima Y.; Progress in Pharmacology and Toxicology, Series Ed, Mannfred A. Hollinger, CRC Press, Taylor & Francis.
Opacka-Juffry, J. (2002) Aromatic Amino Acid Decarboxylase. In: Wiley Encyclopedia of Molecular Medicine, 255-257. John Wiley & Sons, Inc.
Opacka-Juffry J, H. Morris, S. Ashworth, S. Osman, E. Hirani, A.M. MacLeod, S.K. Luthra and S.P. Hume (1998) Preliminary evaluation of the glycine site antagonists [11C]L703,717 and [3H]MDL 105,519 as putative PET ligands for central NMDA receptors-in vivo studies in rats, in Carson, R.E., M.Daube-Witherspoon and P. Herscovitch, Quantitative Functional Brain Imaging with Positron Emission Tomography, San Diego, USA: Academic Press 299-303.